Grifols, S.A.: Connections & Networks - List of connected companies (2024)

Delayed Berne S.E. Other stock markets			5-day change	1st Jan Change
- ^CHF	-.--%		-.--%	-.--%

Aug. 01	Bank Stocks Lead European Equities Traded in the US as American Depositary Receipts Sharply Lower Thursday	MT
Jul. 31	GRIFOLS : Operational improvements continued in the Q2; guidance maintained

14

Listed companies

19

Private companies

51

Insiders

Relation chart of related listed companies: Grifols, S.A.

Active Relations

Past Relations

Related listed companies: Grifols, S.A.

BIOTEST AG

Tomás Dagá Gelabert

Raimon Grifols Roura

David Bell

SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.

Tomás Dagá Gelabert

David Bell

ALCON INC.

Thomas Heinrich Glanzmann

FAES FARMA, S.A.

Nuria Pascual Lapeña

Relationship chart for related private companies: Grifols, S.A.

Active Relations

Past Relations

Related private companies: Grifols, S.A.

Grifols USA, Inc.

Connection statistics

Active

Inactive

Listed companies

Private companies

Activities of related companies

Pharmaceuticals: Major	7
Miscellaneous Commercial Services	4
Medical Specialties	3
Biotechnology	3
Medical/Nursing Services	2
Major Banks	2
Pharmaceuticals: Other	2
Real Estate Development	1
Medical Distributors	1
Investment Managers	1

Countries of related companies

Spain	13
United States	8
Canada	2
United Kingdom	2
Sweden	2
Switzerland	2
Netherlands	1
France	1
China	1
Germany	1

Company Profile

Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows:- products derived from plasma (84.3%): products for use by the pharmaceutical and biotechnology industries;- diagnostic machines and reagents (10.2%): in vitro hemophilic diagnostic equipment, coagulation analyzers, infectious serology reagents, etc. for use primarily by blood banks and transfusion centers;- hospital products (2.4%): non-biological surgical products, radiology and nutritional products, etc. for use by hospital pharmacies;- other (3.1%): primarily intermediate biological products and subcontracted manufacturing services.Net sales are distributed geographically as follows: Spain (5.5%), European Union (13.6%), the United States and Canada (59.1%) and other (21.8%).

Employees

Sector

Pharmaceuticals

Calendar

2024-10-09 - Investors Day

Related indices

IBEX 35

More about the company

Stock Market
Equities
GRF Stock
OZTA Stock
Company Grifols, S.A.
Connections

Our Free Content Help you Secure and Increase the Performance of Your Investments Secure my Investments

"); for (var element in ICConf) { if (document.getElementById("zpp"+element)) { document.getElementById("zpp"+element).innerHTML = ""; } } InvestingChannelQueue.push(function() { ic_page = InvestingChannel.UAT.Run("5c5a75c3-8896-4592-98f8-dc06e6fdcc56"); }); } gaEvent('adspv', 'InvestingChannel_v2', 'US');googletag.cmd.push(function() { googletag.pubads().setTargeting('Edition', 'en_US');googletag.pubads().setTargeting('UserType', 'free');googletag.pubads().setTargeting('Content', 'equities');googletag.pubads().setTargeting('codezb', '149357694');googletag.enableServices();googletag.pubads().collapseEmptyDivs();try{googletag.pubads().getSlots().forEach(function(slot){if(slot.getSlotElementId().startsWith('zpp')){;}else{googletag.pubads().refresh([slot],{changeCorrelator: false});}})}catch(error){console.error(error)}});$(document).ready(function() { $( document).on('zbv_visible',function () {startAdsService();}); if (document[zbv_hidden]===false) { startAdsService(); } });